Trials / Sponsors / Phost'In Therapeutics
Phost'In Therapeutics
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Malignant Tumor, Advanced Solid Tumor, Glioblastoma Multiforme | Phase 1 | 2022-07-18 |